loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 202894 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE (1)

filter

01 GLENMARK PHARMS (1)

filter

01 CREAM;TOPICAL (1)

filter

01 EQ 0.05% BASE;1% (1)

filter

01 USA (1)

URL Supplier Web Content
CREAM;TOPICAL
EQ 0.05% BASE;1%
CLOTRIMAZOLE AND BETAM...
USA
202894
2015-10-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 202894

Looking for CTD TGA MCC DOSSIER APPLICATION 202894 1

19

Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE, with a corresponding application number 202894 and regulatory information .

proudly manufactured in the

approval since 2015-10-30

Glenmark Pharmaceuticals's CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM;TOPICAL, medication with EQ 0.05% BASE;1% of BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE.

Post Enquiry
POST ENQUIRY